glp-1 omaha ne Medical Weight Loss glp-1 omaha ne Find the

Are you using GLP-1s and struggling with side effects that make sticking to your treatment plan feel impossible

Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials

Miller 2003

Oxidative stress in COPD

Lancet Gastroenterol Hepatol (2017) 2(12):8909

Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, et al